Central Pharmaceuticals Ltd

Nature of business The principal activities of the Company throughout the year continued to be manufacturing and marketing of quality medicine.
Subscription open 26 May 2013
Subscription close 30 May 2013
Subscription close for NRB 26 May 2013 to 08 Jun 2013
Offer price Tk. 10.0
Face value per share Tk. 10.0
Market lot 500 units
Single lot price Tk. 5000.0
EPS
NAV
Public offer
Major product The Company is producing and marketing finished formulation products for general Peoples, Hospitals, Clinic, Govt. Organizations, NGO’s, Corporations & other Non-govt. Organizations
Issue Manager Janata Capital and Investment Limited
Website www.centralphl.com

BDIPO_ad_id